Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome

Journal:
Circulation
Published:
DOI:
10.1161/circulationaha.125.073855
Affiliations:
21
Authors:
18
Institutions Authors Share
Leiden University Medical Center (LUMC), Netherlands
2.500000
0.14
Sanofi US, United States of America (USA)
2.000000
0.11
University of California, San Diego (UC San Diego), United States of America (USA)
2.000000
0.11
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
1.666667
0.09
Auckland City Hospital (ACH), New Zealand
1.000000
0.06
Regeneron Pharmaceuticals, United States of America (USA)
1.000000
0.06
The University of Alabama at Birmingham (UAB), United States of America (USA)
1.000000
0.06
Mount Sinai Heart, United States of America (USA)
1.000000
0.06
non-affiliated author contributions, United States of America (USA)
1.000000
0.06
Instituto Cardiovascular de Rosario (ICR), Argentina
1.000000
0.06
St. Michael's Hospital, Canada
0.833333
0.05
Peter Munk Cardiac Centre, Canada
0.833333
0.05
ICIN - Netherlands Heart Institute, KNAW, Netherlands
0.500000
0.03
CPC Clinical Research, United States of America (USA)
0.333333
0.02
SUNY Downstate Health Sciences University (SUNY Downstate), United States of America (USA)
0.333333
0.02
French Alliance for Cardiovascular Trials (FACT), France
0.250000
0.01
University Institute of France (IUF), France
0.250000
0.01
Laboratory for Vascular Translational Science (LVTS), France
0.250000
0.01
Bichat-Claude Bernard Hospital, France
0.250000
0.01